These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2897481)

  • 21. [Histamine H2-receptor antagonists as new anti-ulcer agents].
    Takemoto T
    Nihon Rinsho; 1984 Jan; 42(1):103-13. PubMed ID: 6143835
    [No Abstract]   [Full Text] [Related]  

  • 22. Medical treatment of peptic ulcers.
    Deveney CW; Deveney KE
    Surg Annu; 1985; 17():219-33. PubMed ID: 3883541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Recent developments in drugs antagonistic to factors causing peptic ulcer--clinical effects and problems; histamine H2 receptor blockaders].
    Tani N; Miwa T
    Nihon Rinsho; 1988 Jan; 46(1):12-7. PubMed ID: 2897482
    [No Abstract]   [Full Text] [Related]  

  • 24. [Efficacy of quadruple therapy in the eradication of Helicobacter pylori and prevention of recurrent duodenal ulcer].
    Ocaña Andrade E; Espinosa Soberanes JA; Mares Zambrano MA; Rosete Reyes A
    Rev Gastroenterol Mex; 1998; 63(4):182-6. PubMed ID: 10319667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Complementary medicine. Phytotherapy in gastrointestinal ulcer].
    Praxis (Bern 1994); 2004 Apr; 93(16):682-3. PubMed ID: 15127989
    [No Abstract]   [Full Text] [Related]  

  • 26. Safety and efficacy of roxatidine acetate. Evidence from pharmacodynamic and clinical trials.
    Merki HS; Bender W; Labs R
    J Clin Gastroenterol; 1989; 11 Suppl 1():S20-3; discussion S24. PubMed ID: 2572621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ranitidine v. cimetidine in peptic ulcer.
    Drug Ther Bull; 1982 Jul; 20(15):57-9. PubMed ID: 6128213
    [No Abstract]   [Full Text] [Related]  

  • 28. [Drug administration schedule of anti-ulcer agents to prevent recurrence of peptic ulcer; problems on standardization of the appropriate time for the withdrawal of anti-ulcer agents].
    Takemoto T; Yanai H
    Nihon Rinsho; 1988 Jan; 46(1):133-9. PubMed ID: 3373746
    [No Abstract]   [Full Text] [Related]  

  • 29. Achieving pH control in the critically ill patient: the role of continuous infusion of H2-receptor antagonists.
    Moore JG
    DICP; 1990 Nov; 24(11 Suppl):S28-30. PubMed ID: 1980180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [What is important in treating elderly with H2 receptor antagonists].
    Kurosawa S
    Nihon Rinsho; 2002 Aug; 60(8):1613-7. PubMed ID: 12187760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Strong inhibition of gastric acid secretion: when is it justifiable?].
    Dobrilla G; Amplaz S; Benvenuti S; Bertozzo A
    G Clin Med; 1990; 71(8-9):521-6. PubMed ID: 1980653
    [No Abstract]   [Full Text] [Related]  

  • 32. Hypersensitivity reaction to ranitidine: description of a case and review of the literature.
    Foti C; Cassano N; Panebianco R; Calogiuri GF; Vena GA
    Immunopharmacol Immunotoxicol; 2009; 31(3):414-6. PubMed ID: 19694603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peptic ulcer in cirrhotic patients: a short- and long-term study with antisecretory drugs.
    Di Mario F; Gottardello L; Germanà B; Dotto P; Grassi SA; Vianello F; Battaglia G; Leandro G; Burra P; Salvagnini M
    Ital J Gastroenterol; 1992; 24(3):122-5. PubMed ID: 1348650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Interactions of cimetidine and ranitidine with other drugs].
    Paradowski L; Szelag A
    Pol Tyg Lek; 1988 Aug; 43(35):1120-2. PubMed ID: 2908001
    [No Abstract]   [Full Text] [Related]  

  • 35. Intermittent treatment of duodenal ulcer for long term medical management.
    Bardhan KD
    Postgrad Med J; 1988; 64 Suppl 1():40-6. PubMed ID: 2901744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparative evaluation of cimetidine and ranitidine.
    Zimmerman TW; Schenker S
    Ration Drug Ther; 1985 Apr; 19(4):1-7. PubMed ID: 2932770
    [No Abstract]   [Full Text] [Related]  

  • 37. [Controversies and trends in ulcer therapy. 2: Prevention of recurrence].
    Berndt H
    Z Arztl Fortbild (Jena); 1993 Sep; 87(9):743-8. PubMed ID: 7901948
    [No Abstract]   [Full Text] [Related]  

  • 38. Ranitidine and cimetidine for duodenal ulcer.
    Langman MJ; Henry DA; Ogilvie A
    Scand J Gastroenterol Suppl; 1981 Jun; 69():115-7. PubMed ID: 6119774
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of nizatidine and cimetidine as once-nightly treatment of acute duodenal ulcer. Nizatidine Multicenter Duodenal Ulcer Study Group.
    Cherner JA; Cloud ML; Offen WW; Latz JE
    Am J Gastroenterol; 1989 Jul; 84(7):769-74. PubMed ID: 2568086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Long-term medical prophylaxis of peptic ulcer disease].
    Rohner HG
    Dtsch Med Wochenschr; 1986 Jan; 111(3):117-8. PubMed ID: 2866944
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.